|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operations: | |||||
| Impairment of goodwill, long-lived assets and assets held for sale | |||||
| Impairment of goodwill | |||||
| Impairment of long-lived assets and assets held for sale | |||||
| Total impairment of goodwill, long-lived assets and assets held for sale | |||||
| Depreciation and amortization | |||||
| Net change in operating assets and liabilities | |||||
| Deferred income taxes — net and uncertain tax positions | |||||
| Stock-based compensation | |||||
| Research and development in process | |||||
| Net loss (gain) from sale of business and long-lived assets | |||||
| Other items, net | |||||
| Net cash provided by (used in) operating activities | |||||
| Investing activities: | |||||
| Beneficial interest collected in exchange for securitized trade receivables | |||||
| Purchases of property, plant and equipment and intangible assets | |||||
| Proceeds from sale of business and long lived assets | |||||
| Purchases of investments and other assets | |||||
| Proceeds from sale of investments | |||||
| Acquisitions of businesses, net of cash acquired | |||||
| Other investing activities | |||||
| Net cash provided by (used in) investing activities | |||||
| Financing activities: | |||||
| Repayment of senior notes and loans and other long term liabilities | |||||
| Proceeds from senior notes, net of issuance costs | |||||
| Proceeds from short term debt | |||||
| Repayment of short term debt | |||||
| Redemption of convertible debentures | |||||
| Purchase of shares from redeemable and non-redeemable non-controlling interests | |||||
| Dividends paid to redeemable and non-redeemable non-controlling interests | |||||
| Other financing activities | |||||
| Net cash provided by (used in) financing activities | |||||
| Translation adjustment on cash, cash equivalents and restricted cash | |||||
| Net change in cash, cash equivalents and restricted cash | |||||
| Balance of cash, cash equivalents and restricted cash at beginning of year | |||||
| Balance of cash, cash equivalents and restricted cash at end of year | |||||
| Non-cash financing and investing activities: | |||||
| Beneficial interest obtained in exchange for securitized trade receivables | |||||
| Dividend declared to non-controlling interests | |||||
| Cash paid during the year for: | |||||
| Interest | |||||
| Income taxes, net of refunds | |||||
| Net change in operating assets and liabilities: | |||||
| Other assets | |||||
| Trade payables, accrued expenses, employee-related obligations and other liabilities | |||||
| Trade receivables net of sales reserves and allowances | |||||
| Inventories | |||||
| Net Change In Items Comprising Supplemental Disclosure Of Cash Flow Information | |||||
| Reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheets: | |||||
| Cash and cash equivalents | |||||
| Restricted cash included in other current assets | |||||
Loading...